Bank of Nova Scotia
SAGE

Bank of Nova Scotia’s Sage Therapeutics SAGE Stock Holding History

Bank of Nova Scotia’s Portfolio SAGE Stock Details SAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-87,000
Closed -$2.81M – 1218
2022
Q2 		$2.81M Buy
+87,000
New +$2.92M 0.01% 618
2022
Q1 		– Sell
-44,032
Closed -$1.87M – 1300
2021
Q4 		$1.87M Buy
+44,032
New +$1.84M ﹤0.01% 903
2018
Q2 		– Sell
-13,565
Closed -$2.18M – 936
2018
Q1 		$2.18M Sell
13,565
-38
-0.3% -$6.45K 0.01% 541
2017
Q4 		$2.24M Buy
13,603
+6,503
+92% +$630K 0.01% 584
2017
Q3 		$442K Buy
+7,100
New +$558K ﹤0.01% 849

Other funds holding SAGE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Bank of Nova Scotia's SAGE Position: Q3 2022 in Review

Bank of Nova Scotia sold out of Sage Therapeutics (SAGE) in Q3 2022, closing a stake of 87,000 shares — an estimated $2.81M sold.

Bank of Nova Scotia first reported a position in SAGE in Q3 2017 and held it in 5 quarters. The position peaked at $2.81M in Q2 2022. 201 funds tracked by Wall St. Rank hold SAGE as of Q3 2022.

  • Bank of Nova Scotia reported no remaining Sage Therapeutics position as of Q3 2022 after selling out during the quarter.
  • Bank of Nova Scotia sold 87,000 Sage Therapeutics shares in Q3 2022, an estimated $2.81M.
  • Bank of Nova Scotia first reported a position in Sage Therapeutics in Q3 2017 and held it in 5 quarters.
  • Bank of Nova Scotia's Sage Therapeutics position peaked at $2.81M in Q2 2022.
  • 201 funds tracked by Wall St. Rank held Sage Therapeutics as of Q3 2022.

Based on Bank of Nova Scotia's 13F filing for Q3 2022, filed 10 Nov 2022.